[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work With Us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Making Pharmaceuticals Show
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

Revoked or Suspended Licence?

by Ryan Watts | May 26, 2015 | Blog, Good Distribution Practice - GDP, Licence Acquisition, MHRA, Regulation, RP, WDA(H)

You have just been informed by the Medicines and Healthcare Products Regulatory Agency (MHRA) that they will be suspending your Wholesale Dealers Authorisation (WDA). You are in a panic as you realise you have to cease all trading immediately. Other implications...

They’re All Talking about Chris!

by John Finey | Feb 24, 2015 | Good Distribution Practice - GDP

Who is Chris? I’ll come straight to the point, Chris is a PRAWN SANDWICH and a bit of a media star. Chris is currently doing a tour as an assistant to a series of GDP training courses.   Why is Chris involved? Who is the real Chris and why is a prawn sandwich called...

What system should you use to measure the risks in your business? What system should you use for your risk assessments?

by Kimberley Peck | Feb 17, 2015 | Good Distribution Practice - GDP, Quality Systems

The new GDP guidelines on distributing medicines which are the regulations you must adhere to as a wholesale distributor use the word RISK 27 times. As a wholesale distributor you must access all risks within your business. The easiest way to complete this task is to...

Quality Management Systems for the Wholesale Distribution of Medicines

by Ryan Watts | Dec 19, 2014 | Consultancy, Good Distribution Practice - GDP, Uncategorized, WDA(H)

Is yours up to date? Is it suitable for your business model? Do you have a change control procedure in place? Does your system work?   Why is it needed? Stipulated in the European Guidelines of 2013 that any wholesaler must possess and use a QMS. Public health...

Bona Fides – Do You Know What to Look for When Approving a Supplier or Customer for the Distribution of Medicines?

by Kimberley Peck | Dec 19, 2014 | Bona Fides, EudraGMDP, Good Distribution Practice - GDP, WDA(H)

Is a copy of a WDA(H) enough evidence to approve a supplier? NO! Evidence of a WDA(H) is just one of the steps required for supplier approval. If obtaining the product direct from manufacturer or from another wholesaler the authorisation is no longer enough. The...

GDP/RP Refresher Courses

by Jackie (née Heneghan) Peck | Oct 28, 2014 | Blog, Consultancy, Good Distribution Practice - GDP, RP, Training

If you have, recently, tried to register for the 2014 MHRA GDP symposium, you will have found it to be fully booked. If you have missed your space this year, why not register for one of PCL’s RP update courses? Our GDP/RP courses are held twice a month in the...
« Older Entries
Next Entries »

Recent Posts

  • Are Audit clip boards and checklists obsolete?
  • Major Changes to MHRA Medical Device Registration Fees
  • Major Changes to MHRA Medical Device Registration Fees

Upcoming Courses

  • Export Online Training on 4 February 2026 10:00 am
  • Licence Holder Training on 5 February 2026 10:00 am
  • Superintendent Pharmacist training (Online) on 9 February 2026
  • GDP Audit Online Training on 11 February 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 20 February 2026 10:00 am

MHRA Alerts & Recalls

Class 2 Medicines Recall: Syri Limited, T/A SyriMed, Baclofen 10mg/5ml Oral Solution, EL(26)A/06
3 February 2026
Field Safety Notices: 26-30 January 2026
2 February 2026
Class 2 Medicines Recall: Accord Healthcare Ltd, Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion (1 vial 100mg powder, 1 vial of 3 mL solvent), EL(26)A/05
2 February 2026
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited due to a potential for overdosing, NatPSA/2026/002/MHRA
29 January 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow